Self-sustenance is a concept that is gaining traction globally. It involves the ability to meet one’s own needs without relying on external resources. We a pharmaceutical company based in Gujarat, India produces a range of pharmaceutical products, including active pharmaceutical ingredients (APIs), generic drugs, and nutraceuticals. One of the key raw materials used in the production of APIs is para-aminophenol (PAP), which is used to produce paracetamol. For more information visit: https://www.farmson.com/blogs/self-sustenance-a-motto-at-farmson/
Farmson was established in the year 1971 for manufacturing of Paracetamol through phenol route. In the year 2000, we switched over to the PNCB route to manufacture Paracetamol. Currently, we are the GLOBAL LEADER in API Paracetamol production.
Sunday, 28 May 2023
Self-sustenance a motto at Farmson
Self-sustenance is a concept that is gaining traction globally. It involves the ability to meet one’s own needs without relying on external resources. We a pharmaceutical company based in Gujarat, India produces a range of pharmaceutical products, including active pharmaceutical ingredients (APIs), generic drugs, and nutraceuticals. One of the key raw materials used in the production of APIs is para-aminophenol (PAP), which is used to produce paracetamol. For more information visit: https://www.farmson.com/blogs/self-sustenance-a-motto-at-farmson/
Subscribe to:
Post Comments (Atom)
Research & Development - Driving Innovation at Farmson
Research & Development is the engine behind Farmson’s long-term success in pharmaceutical manufacturing. With a dedicated, state-of-the-...
-
Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology...
-
Farmson has expanded beyond Paracetamol to become a world-class manufacturer of Caffeine API with a dedicated, state-of-the-art synthetic ca...
-
Farmson Basic Drugs, a leader in API manufacturing, expands its innovation with a world-class synthetic caffeine facility designed for pharm...
No comments:
Post a Comment